Hendershot Investments’s GSK GSK Stock Holding History

Hendershot Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,227	Closed	-$153K	–	133
2023 Q3	$153K	Hold	4,227	–	–	0.03%	126
2023 Q2	$151K	Sell	4,227 -320	-7%	-$11.5K	0.02%	135
2023 Q1	$162K	Sell	4,547 -576	-11%	-$20.2K	0.03%	137
2022 Q4	$180K	Sell	5,123 -240	-4%	-$7.99K	0.03%	133
2022 Q3	$158K	Sell	5,363 -424	-7%	-$16.1K	0.03%	134
2022 Q2	$315K	Sell	5,787 -80	-1%	-$4.42K	0.06%	112
2022 Q1	$319K	Hold	5,867	–	–	0.05%	117
2021 Q4	$323K	Buy	+5,867	New	+$305K	0.05%	118

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hendershot Investments's GSK Position: Q4 2023 in Review

Hendershot Investments sold out of GSK (GSK) in Q4 2023, closing a stake of 4,227 shares — an estimated $153K sold.

Hendershot Investments first reported a position in GSK in Q4 2021 and held it in 8 quarters. The position peaked at $323K in Q4 2021. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2023.

Hendershot Investments reported no remaining GSK position as of Q4 2023 after selling out during the quarter.
Hendershot Investments sold 4,227 GSK shares in Q4 2023, an estimated $153K.
Hendershot Investments first reported a position in GSK in Q4 2021 and held it in 8 quarters.
Hendershot Investments's GSK position peaked at $323K in Q4 2021.
895 funds tracked by Wall St. Rank held GSK as of Q4 2023.

Based on Hendershot Investments's 13F filing for Q4 2023, filed 26 Jan 2024.